Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Horizon Technology Finance
AddedFeb 13, 2024
UpdatedJun 28, 2026
Horizon Technology Finance

Horizon Technology Finance

Acquired

Horizon, a venture lending platform, provides structured debt products to tech and life science firms.

Location
Farmington, CT, US
Founded
2003
Firm
Compare
Portfolio
Fundraising
Employees
Website

Investments

Parse Biosciences
Parse Biosciences

Total Raised

$100M

Rounds

6

Debt FinancingDecember 2023
Mirantis
Mirantis

Total Raised

$240M

Rounds

6

Debt Financing$20MOctober 2023
Elligo Health Research
Elligo Health Research

Total Raised

$196M

Rounds

6

Debt Financing$25MOctober 2023
Sonex Health
Sonex Health

Total Raised

$90.1M

Rounds

8

Debt FinancingSeptember 2023
Debt Financing$7.5MNovember 2020
Tallac Therapeutics
Tallac Therapeutics

Total Raised

$88.2M

Rounds

3

Debt Financing$5MAugust 2023
Viken Detection
Viken Detection

Total Raised

$25.9M

Rounds

6

Debt Financing$10MJune 2023
SafelyYou
SafelyYou

Total Raised

$71.3M

Rounds

8

Debt Financing$10MMay 2023
Unagi Scooters
Unagi Scooters

Total Raised

$41M

Rounds

4

Series A$10MApril 2023
Slingshot Aerospace
Slingshot Aerospace
Debt

Total Raised

$117.4M

Rounds

12

Series ADecember 2022
Kodiak AI
Kodiak AI

Total Raised

$319.9M

Rounds

7

Debt Financing$30MOctober 2022
Inbrace
Inbrace

Total Raised

$217.6M

Rounds

7

Debt Financing$45MJuly 2022
Divergent
Divergent

Total Raised

$769M

Rounds

8

Debt Financing$80MJuly 2022
Soli Organic
Soli Organic

Total Raised

$487.5M

Rounds

13

Debt Financing$50MMay 2022
Secure Transfusion Services
Secure Transfusion Services

Total Raised

$15M

Rounds

1

Debt Financing$15MMarch 2022
Aerobiotix
Aerobiotix

Total Raised

$35M

Rounds

2

Debt Financing$10MMarch 2022
Interior Define
Interior Define

Total Raised

$57.2M

Rounds

11

Debt Financing$30MJanuary 2022
Everstream Analytics
Everstream Analytics

Total Raised

$79M

Rounds

3

Debt Financing$5MNovember 2021
Stealth BioTherapeutics
Stealth BioTherapeutics
Public

Total Raised

$191.4M

Rounds

8

Post Ipo Debt$25MOctober 2021
Nogin
Nogin
Public

Total Raised

$97M

Rounds

4

Debt Financing$15MAugust 2021
The RepTrak Company
The RepTrak Company
Public

Total Raised

$10M

Rounds

1

Debt Financing$10MJuly 2021
LiquiGlide
LiquiGlide

Total Raised

$44.6M

Rounds

7

Debt Financing$8MJune 2021
Alula Holdings
Alula Holdings

Total Raised

$28M

Rounds

2

Debt Financing$13MJanuary 2021
Corinth MedTech
Corinth MedTech

Total Raised

$17M

Rounds

2

Debt Financing$5MDecember 2020
Getaround
Getaround
Public

Total Raised

$763M

Rounds

20

Debt Financing$25MNovember 2020